Study on invasive bacterial diseases and their epidemiology
Epidemiological Study on Invasive Bacterial Diseases (IBD)
This study is trying to see how well new testing methods can identify serious bacterial infections in patients to help improve treatments and vaccination strategies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 1 Day to 70 Years |
| Sex | All |
| Sponsor | Meyer Children's Hospital IRCCS Academic / other |
| Locations | 38 sites (Adria and 37 other locations) |
| Trial ID | NCT06322290 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the epidemiology of invasive bacterial diseases caused by Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. It aims to improve pathogen identification through molecular diagnostic methods, which can detect bacteria even when they are not viable. By analyzing blood specimens from patients, the study seeks to characterize circulating strains and assess the impact of vaccination strategies. The findings will guide public health interventions and improve treatment and prevention strategies for these serious infections.
Who should consider this trial
Good fit: Ideal candidates for this study are pediatric and adult patients diagnosed with pneumococcal, meningococcal, or hemophilus invasive bacterial infections.
Not a fit: Patients with other types of bacterial infections will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of diagnosing invasive bacterial diseases and inform better public health strategies, potentially reducing the incidence of these infections.
How similar studies have performed: Other studies utilizing molecular diagnostic methods for pathogen identification have shown promise, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pediatric and adult patients diagnosed with pneumococcal, meningococcal, and hemophilus MBI Exclusion Criteria: * Other type of bacterial infections.
Where this trial is running
Adria and 37 other locations
- Ospedale di Adria — Adria, Italy (Not_yet_recruiting)
- Ospedali riuniti di Ancona — Ancona, Italy (Not_yet_recruiting)
- Ospedale di Andria — Andria, Italy (Not_yet_recruiting)
- Ospedale Giovanni XXIII — Bari, Italy (Not_yet_recruiting)
- Policlinico S.Orsola-Malpighi IRCCS — Bologna, Italy (Not_yet_recruiting)
- Fondazione poliambulanza Brescia — Brescia, Italy (Not_yet_recruiting)
- Ospedale Giovanni XXIII — Brescia, Italy (Not_yet_recruiting)
- Ospedale di Campobasso — Campobasso, Italy (Not_yet_recruiting)
- Ospedale Camposampiero — Camposampiero, Italy (Not_yet_recruiting)
- Ospedale di Esine asst Valcamonica — Esine, Italy (Not_yet_recruiting)
- Ospedale di Feltre (AULSS 1 Dolomiti) — Feltre, Italy (Not_yet_recruiting)
- Immunology Laboratory Meyer Children's Hospital IRCCS — Florence, Italy (Recruiting)
- Ospedale Morgagni — Forlì, Italy (Not_yet_recruiting)
- AO Salvini di Garbagnate — Garbagnate, Italy (Not_yet_recruiting)
- Azienda sanitaria universitaria Giuliano Isontina (ASU GI) — Gorizia, Italy (Not_yet_recruiting)
- Ospedale di Magenta — Magenta, Italy (Not_yet_recruiting)
- Azienda Ospedaliera Policlinico Universitario "G. Martino" — Messina, Italy (Not_yet_recruiting)
- IRCCS San Raffaele — Milan, Italy (Not_yet_recruiting)
- AORN Santobono — Naples, Italy (Not_yet_recruiting)
- AOU Federico II di Napoli — Naples, Italy (Not_yet_recruiting)
- Ospedale di Novara — Novara, Italy (Not_yet_recruiting)
- Fondazione I.R.C.C.S. Policlinico San Matteo — Pavia, Italy (Not_yet_recruiting)
- Ospedale spirito santo di Pescara — Pescara, Italy (Not_yet_recruiting)
- Azienda sanitaria Friuli occidentale — Pordenone, Italy (Not_yet_recruiting)
- Ospedale di Macerata — Province of Macerata, Italy (Not_yet_recruiting)
- Ospedale degli infermi — Rimini, Italy (Not_yet_recruiting)
- Ospedale Pediatrico Bambin Gesù IRCCS — Roma, Italy (Not_yet_recruiting)
- Ospedale Sandro Pertini — Roma, Italy (Not_yet_recruiting)
- Ospedale San Leonardo di Salerno — Salerno, Italy (Not_yet_recruiting)
- Ospedale di Saronno — Saronno, Italy (Not_yet_recruiting)
- AOU Sassari — Sassari, Italy (Not_yet_recruiting)
- Ospedale di Scorrano — Scorrano, Italy (Not_yet_recruiting)
- ASP Trapani — Trapani, Italy (Not_yet_recruiting)
- IRCCS Materno Infantile Burlo Garofolo — Trieste, Italy (Not_yet_recruiting)
- Azienda sanitaria universitaria Friuli Centrale (ASU FC) — Udine, Italy (Not_yet_recruiting)
- Azienda ospedaliera universitaria integrata Verona — Verona, Italy (Not_yet_recruiting)
- Ospedale civile di Vibo Valentia — Vibo Valentia, Italy (Not_yet_recruiting)
- Ospedale Maggiore Carlo Alberto Pizzardi — Bologna, Ì, Italy (Not_yet_recruiting)
Study contacts
- Study coordinator: Chiara Azzari, MD
- Email: chiara.azzari@meyer.it
- Phone: 00390555662542
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.